Senior insider sale
KEROS THERAPEUTICS, INC. — senior position signals high conviction
$5.5K
550.00 shares
What this filing means
NEWTON CHARLES W. plans to sell 550.00 shares of KEROS THERAPEUTICS, INC. valued at approximately $5.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/11/2026ACC: 0001969223-26-000680
Director
Since Mar 2026
550.00
Shares to sell
$5.5K
Approx. market value
550.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
RSU
N/A
5/15/2026
550.00Total acquired550.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | RSU N/A | 550.00 | — |
| Total | 550.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
550.00
Market value
$5.5K
6/11/2026
Total
Units
550.00
Value
$5.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/11/2026 | 550.00 | $5.5K | NASDAQ | Planned |
| Total | 550.00 | $5.5K | ||